Jazz Pharmaceuticals to Participate in the 2025 Wells Fargo Healthcare Conference

About this update from Jazz Pharmaceuticals Plc

[{"type":"text","content":"DUBLIN, Aug. 21, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2025 Wells Fargo Healthcare Conference. Company management will participate in a fireside chat on Wednesday, September 3, 2025, at 6:30 a.m. PDT / 9:30 p.m. EDT / 2:30 p.m. IST.\nAn audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.\nAudio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.\nAbout Jazz PharmaceuticalsJazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.\nContacts:Investors: Jack SpinksExecutive Director, Investor RelationsJazz Pharmaceuticals [email protected] +353 1 634 3211U.S. +1 650 496 2717\nMedia:Kristin BhavnaniHead of Global Corporate CommunicationsJazz Pharmaceuticals [email protected] +353 1 637 2141U.S. +1 215 867 4948\n\n\n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-the-2025-wells-fargo-healthcare-conference-302533954.html\nSOURCE Jazz Pharmaceuticals plc","length":5152,"tagName":"div"}]

More updates from Jazz Pharmaceuticals Plc